These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24877662)

  • 1. Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. Clear Code34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84.
    Parker AS; Leibovich BC; Eckel-Passow JE; Cheville JC
    Eur Urol; 2014 Nov; 66(5):e90-1. PubMed ID: 24877662
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Alexander S. Parker, Brad C. Leibovich, Jeanette E. Eckel-Passow, John C. Cheville's letter to the editor re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84.
    Rathmell WK; Brooks SA; Parker JS; Nielsen ME
    Eur Urol; 2014 Nov; 66(5):e92. PubMed ID: 25037640
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma.
    Laguna MP
    J Urol; 2015 Jan; 193(1):71-2. PubMed ID: 25523651
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: A. Rose Brannon, Scott M. Haake, Kathryn E. Hacker, et al. Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. Eur Urol 2012;61:258-68.
    Williamson SR; Eble JN; Cheng L; Grignon DJ
    Eur Urol; 2012 Oct; 62(4):e81-2. PubMed ID: 22790289
    [No Abstract]   [Full Text] [Related]  

  • 5. The molecular biology of renal cancer: another piece of the puzzle.
    Stewart GD; Harrison DJ; Berney DM; Powles T
    Eur Urol; 2014 Jul; 66(1):85-6. PubMed ID: 24674147
    [No Abstract]   [Full Text] [Related]  

  • 6. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.
    Brooks SA; Brannon AR; Parker JS; Fisher JC; Sen O; Kattan MW; Hakimi AA; Hsieh JJ; Choueiri TK; Tamboli P; Maranchie JK; Hinds P; Miller CR; Nielsen ME; Rathmell WK
    Eur Urol; 2014 Jul; 66(1):77-84. PubMed ID: 24613583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol 2013;64:689-91.
    Verine J; Leboeuf C; Ratajczak P
    Eur Urol; 2014 May; 65(5):e69-70. PubMed ID: 24341959
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Jérôme Verine, Christophe Leboeuf and Philippe Ratajczak's letter to the editor re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol 2013;64:689-91.
    Sanjmyatav J; Hartmann A; Moch H; Hauke S; Gajda M; Meyer B; Pryalukhin A; Grimm MO; Junker K
    Eur Urol; 2014 May; 65(5):e71-2. PubMed ID: 24332347
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
    Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
    Liu Y; Liu H; Liu W; Zhang W; An H; Xu J
    World J Urol; 2015 Nov; 33(11):1791-9. PubMed ID: 25630622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression in clear cell renal cell carcinoma identified by gene expression profiling.
    Lane BR; Li J; Zhou M; Babineau D; Faber P; Novick AC; Williams BR
    J Urol; 2009 Feb; 181(2):849-60. PubMed ID: 19095258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma.
    Flippot R; Mouawad R; Spano JP; Rouprêt M; Compérat E; Bitker MO; Parra J; Vaessen C; Allanic F; Manach Q; Tannir NM; Khayat D; Su X; Malouf GG
    Sci Rep; 2017 Aug; 7(1):8540. PubMed ID: 28819235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Stanley Weng, Renzo G. DiNatale, Andrew Silagy, et al. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management. Eur Urol 2021;79:468-77.
    Gupta S; Pitel BA; Knight SM; Halling KC; Jimenez RE; Cheville JC
    Eur Urol; 2021 Aug; 80(2):e62-e63. PubMed ID: 34020826
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
    Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
    J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Sunao Shoji, Xian Yan Tang, Shinobu Umemura, et al. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Eur Urol 2009;55:441-51.
    Chen Y; Kovacs G
    Eur Urol; 2009 Apr; 55(4):e76; author reply e77. PubMed ID: 18834661
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
    White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
    Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma.
    Wu G; Xu Y; Li L; Li J; Ruan N; Dong J; Si Z; Xia Q; Wang Q
    Int J Med Sci; 2020; 17(18):2905-2916. PubMed ID: 33173411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma.
    Goldberg H
    Ann Surg Oncol; 2021 Apr; 28(4):1889-1891. PubMed ID: 33554287
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Alexa R. Meyer, Steven P. Rowe, and Nirmish Singla's Letter to the Editor re: Patrick D. McGillivray, Daiki Ueno, Aydin Pooli, et al. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier. Eur Urol 2021;79:107-11. Integrating
    Shuch B; Raman S; Calais J
    Eur Urol; 2021 Jul; 80(1):e22-e23. PubMed ID: 33941405
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.
    Slaby O; Jancovicova J; Lakomy R; Svoboda M; Poprach A; Fabian P; Kren L; Michalek J; Vyzula R
    J Exp Clin Cancer Res; 2010 Jul; 29(1):90. PubMed ID: 20609231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.